- Sentia Wellness recently laid off several workers due to uncertainty with the FDA’s lack of CBD regulation.
- According to sources, between 30 and 40 workers were laid off.
- Despite these layoffs, Sentia is rolling out a line of new CBD-infused topical products by the end of 2020.
Sentia Wellness, an Oregon-based CBD company, recently laid off dozens of workers after launching less than 5 months prior. Sentia Wellness did not provide an exact number, but according to multiple sources, between 30 and 40 workers were laid off.
Located in Portland, Oregon, Sentia is a spinoff business of Cura Cannabis, a marijuana company in Oregon that recently paid a hefty fine to the state in order to settle charges that involved Cura claiming their vape products to be pure marijuana even though they included several additives.
When they first started, Sentia raised around $90 million and employed 150 workers to begin their own line of CBD products. But with continuing confusion and lack of regulation from the U.S. Food and Drug Administration (FDA), they were unable to proceed with confidence.
Elana Weiss, a spokeswoman for the company, stated:
“The FDA’s decision … to not provide regulatory clarity to the CBD industry has real world consequences. This layoff is one of them.”
These layoffs closely resemble that of another cannabis company, named Mile High Labs, who also laid off several workers at the beginning of this year.
Light at the End of the Tunnel
Despite these layoffs, Sentia Wellness was chosen by Authentic Brands Group (owner of Sports Illustrated brands) early last month to produce a line of CBD-infused topical products by the end of 2020. One of the products includes a recovery cream that contains 500 milligrams of CBD.
Once the FDA eventually provides regulations for CBD and its industry, companies like Sentia will truly begin to heal and flourish in a consumer’s market that has a high demand for these products.
While the layoffs at Sentia Wellness may seem like a big deal, it is important to understand that companies typically execute them in a manner that is intended to reduce their amount of loss while also letting go of certain people that may not be a good fit for the company, ultimately making the situation a positive in the long run. If Sentia’s biggest roadblock is the lack of regulation from the FDA, then it makes sense for them to cut their losses and focus on the quality of their upcoming products.